Document is current
Any future updates will be listed below
-
Authors
Hirohata, Kiichi
Kino, Shinichiro
Yamane, Takuya
Bandoh, Karin
Bamba, Takeshi
Sternisha, Shawn M.
Torisu, Tetsuo
Fukuhara, Mitsuko
Yamaguchi, Yuki
Uchiyama, Susumu https://orcid.org/0000-0002-5181-179X
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP18ae0201001, JP18ae0201002)
The University of Osaka
- License Information
-
More Information
Article History
Received: 30 January 2025
Revised: 27 March 2025
Accepted: 9 April 2025
First Online: 19 May 2025
Declarations
:
: T.Y. is a founder and Chief Executive Officer (CEO) of BYU-Analytica Inc., Japan. T.B. is Chief Technology Officer (CTO) of BYU-Analytica Inc. S.M.S is employed by Beckman Coulter Life Sciences, USA. M.F is employed by U-Medico Inc., Japan. S.U. is a founder and Chief Scientific Officer (CSO) of U-Medico Inc., and CSO of BYU-Analytica Inc.
